Human amnion-derived mesenchymal stem cells induced osteogenesis and angiogenesis in human adipose-derived stem cells via ERK1/2 MAPK signaling pathway

BMB Rep. 2018 Apr;51(4):194-199. doi: 10.5483/bmbrep.2018.51.4.005.

Abstract

Mesenchymal stem cells (MSCs) have shown great potential in treating bone deficiency. Human adipose-derived stem cells (HASCs) are multipotent progenitor cells with multi-lineage differentiation potential. Human amnion-derived mesenchymal stem cells (HAMSCs) are capable of promoting osteogenic differentiation of MSCs. In this study, we investigated the effect of HAMSCs on HASCs by a transwell co-culture system. HAMSCs promoted proliferation, osteogenic differentiation, angiogenic potential and adiponectin (APN) secretion of HASCs. Moreover, the positive effect of HAMSCs was significantly inhibited by U0126, a highly selective inhibitor of extracellular signaling-regulated kinase 1/2 (ERK1/2) mitogen-activated protein kinase (MAPK) signaling pathway. These observations suggested that HAMSCs induced bone regeneration in HASCs via ERK1/2 MAPK signaling pathway. [BMB Reports 2018; 51(4): 194-199].

MeSH terms

  • Adipocytes / metabolism
  • Adipose Tissue / cytology
  • Amnion / cytology*
  • Amnion / enzymology*
  • Amniotic Fluid / cytology
  • Amniotic Fluid / enzymology
  • Cell Differentiation / drug effects
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Humans
  • MAP Kinase Kinase 1 / metabolism
  • MAP Kinase Signaling System*
  • Mesenchymal Stem Cells / cytology*
  • Mesenchymal Stem Cells / enzymology*
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Neovascularization, Physiologic / drug effects
  • Osteogenesis / drug effects*
  • Osteogenesis / physiology
  • Stem Cells / cytology
  • Stem Cells / enzymology

Substances

  • Mitogen-Activated Protein Kinase 1
  • MAP Kinase Kinase 1